Continue to site >
Trending ETFs

Name

As of 04/23/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$19.02

$28.2 M

0.00%

1.58%

Vitals

YTD Return

1.7%

1 yr return

8.5%

3 Yr Avg Return

N/A

5 Yr Avg Return

N/A

Net Assets

$28.2 M

Holdings in Top 10

17.8%

52 WEEK LOW AND HIGH

$18.7
N/A
N/A

Expenses

OPERATING FEES

Expense Ratio 1.58%

SALES FEES

Front Load N/A

Deferred Load N/A

TRADING FEES

Turnover N/A

Redemption Fee N/A


Min Investment

Standard (Taxable)

$100,000

IRA

N/A


Fund Classification

Fund Type

Open End Mutual Fund


Name

As of 04/23/2024

Price

Aum/Mkt Cap

YIELD

Annualized forward dividend yield. Multiplies the most recent dividend payout amount by its frequency and divides by the previous close price.

Exp Ratio

Expense ratio is the fund’s total annual operating expenses, including management fees, distribution fees, and other expenses, expressed as a percentage of average net assets.

Watchlist

$19.02

$28.2 M

0.00%

1.58%

SKGIX - Profile

Distributions

  • YTD Total Return 1.7%
  • 3 Yr Annualized Total Return N/A
  • 5 Yr Annualized Total Return N/A
  • Capital Gain Distribution Frequency Annually
  • Net Income Ratio N/A
DIVIDENDS
  • Dividend Yield 0.0%
  • Dividend Distribution Frequency Annual

Fund Details

  • Legal Name
    Steward Small Cap Growth Fund
  • Fund Family Name
    Crossmark Global Investments, Inc.
  • Inception Date
    Nov 15, 2021
  • Shares Outstanding
    N/A
  • Share Class
    Instl
  • Currency
    USD
  • Domiciled Country
    US
  • Manager
    Brent Lium

Fund Description

The Fund’s principal investment strategy is to invest in a portfolio of small‑cap growth securities, subject to the limitations of the Fund’s values-based screening policies (see “Values-based Screens” below). Under normal market conditions, the Fund invests at least 80% of its assets in securities of small‑cap companies.* Small‑cap companies are defined as those with market capitalizations no larger than the largest capitalized issuer included in the Fund’s benchmark index from time to time, which, as of June 30, 2023, had a market capitalization of $13.1 billion. The Fund’s benchmark index is a widely recognized broad-based small‑cap growth index and is the same index identified in the Average Annual Total Returns table below.
The Fund invests primarily in equity securities. The principal type of equity security in which the Fund invests is common stock. The Fund may also invest in other investment companies and up to 15% of its net assets in real estate investment trusts.
The Fund invests primarily in securities that are considered by portfolio management to have potential for earnings or revenue growth. The security
*
The 80% is measured as of the time of investment and is applied to the value of the Fund’s net assets plus the amount of any borrowings for investment purposes. For purposes of this limit, investments include those made directly or through other investment companies that have substantially similar 80% policies. The Fund will provide shareholders with at least 60 days’ prior notice of any change in this policy.
selection process is based on a three-step process that includes fundamental, valuation and timeliness analysis:
Fundamental analysis involves building a series of financial models. The goal is to find high quality, fundamentally sound issuers operating in an attractive industry.
Valuation analysis focuses on identifying attractively valued securities given their growth potential over a one‑ to two‑year horizon.
Timeliness analysis is used to help identify the “timeliness” of a purchase. In this step, relative price strength, trading volume characteristics and trend analysis are reviewed for signs of deterioration. If a security shows signs of deterioration, it will not be considered as a candidate for the portfolio.
Portfolio management considers selling a security if the investment thesis for owning the security is no longer valid, the stock reaches its price target or timeliness factors indicate that the risk/return characteristics of the stock are viewed in the market as no longer attractive.
Portfolio management may consider, among other factors, a company’s valuation, financial strength, growth potential, competitive position in its industry, projected future earnings, cash flows and dividends when deciding whether to buy or sell investments. When making investment decisions, portfolio management may also consider whether a company, through its activities, both externally and internally, seeks to reduce risk and create long-term resilience through sustainable and responsible business practices, as determined based on data and rankings generated by one or more third-party providers unaffiliated with Crossmark. Crossmark believes that such companies exhibit positive values, including, but not limited to, the fair treatment of employees, respect for the environment, positive engagement with the communities in which they operate, and responsible governance practices. To the extent two or more securities eligible for inclusion in the Fund’s portfolio have similar economic characteristics, portfolio management will typically prefer the securities of the companies that it determines compare more favorably with respect to such positive values.
Values-based Screens. As noted above, in implementing its investment strategies, the Fund applies a set of values-based screens to use its best efforts to avoid investing in companies that are determined by Crossmark, pursuant to screening guidelines approved by the Fund’s Board of Directors, to be: (1) materially involved in the production, distribution, retail, supply or licensing of alcohol or related products; (2) materially involved in the production, distribution, retail, supply or licensing of tobacco or related products (to include vaping and other alternative smoking products); (3) materially involved in gambling (to include the manufacture, distribution and operation of facilities and equipment whose intended use is gambling); (4) directly participating in providing abortions and/or the production of drugs that are used to terminate pregnancy; (5) leasing real estate to facilities providing abortions; (6) directly
engaged in scientific research using stem cells derived from human embryos, fetal tissue or human embryo cloning techniques; (7) directly involved in the production, distribution or retail of adult entertainment; or (8) directly involved in the production, distribution, retail, supply or licensing of psychoactive recreational cannabis or derivative products. Because the Fund uses its best efforts to avoid investments in companies that do not pass the values-based screening criteria, it will divest itself, in a timely manner, of securities of companies that are subsequently added to the list of prohibited companies, although the sale may be delayed if such securities are illiquid or if Crossmark determines that an immediate sale would have a negative tax or other effect on the Fund. However, the Fund may invest up to 5% of its total assets in certain collective investment vehicles or derivatives that may hold or derive value from securities issued by otherwise excluded companies.
For purposes of the alcohol, tobacco and gambling screens, material involvement means that a company derives 10% or more of its revenues from the screened activities. For purposes of the adult entertainment screen, companies directly involved in the production, distribution or retail of adult entertainment (defined as media and materials intended to appeal exclusively to the prurient interest) and companies that derive 2% or more of their revenues from the screened activities are screened. For purposes of the abortion, abortion facilities, stem cell research and cannabis screens, there is no revenue threshold; any direct involvement in the screened activities will cause a company to be screened out of the investment universe. For purposes of the abortion and abortion facilities screens, a company that is not itself directly involved in the screened activities will be screened out of the investment universe if (a) it owns 20% or more of another company that is directly participating in the screened activities, or (b) it is 50% or more owned by another company that is directly participating in the screened activities.
Read More

SKGIX - Performance

Return Ranking - Trailing

Period SKGIX Return Category Return Low Category Return High Rank in Category (%)
YTD 1.7% -11.0% 9.4% 55.18%
1 Yr 8.5% -7.5% 45.3% 79.23%
3 Yr N/A* -26.1% 57.2% N/A
5 Yr N/A* -5.1% 43.7% N/A
10 Yr N/A* 0.8% 23.7% N/A

* Annualized

Return Ranking - Calendar

Period SKGIX Return Category Return Low Category Return High Rank in Category (%)
2023 15.3% -20.5% 54.6% 43.66%
2022 N/A -82.1% 32.2% N/A
2021 N/A -90.6% 300.1% N/A
2020 N/A -63.0% 127.9% N/A
2019 N/A -7.7% 42.9% N/A

Total Return Ranking - Trailing

Period SKGIX Return Category Return Low Category Return High Rank in Category (%)
YTD 1.7% -11.0% 9.4% 55.18%
1 Yr 8.5% -7.5% 45.3% 79.23%
3 Yr N/A* -26.1% 57.2% N/A
5 Yr N/A* -5.1% 43.7% N/A
10 Yr N/A* 0.8% 23.7% N/A

* Annualized

Total Return Ranking - Calendar

Period SKGIX Return Category Return Low Category Return High Rank in Category (%)
2023 15.3% -19.0% 136.8% 56.69%
2022 N/A -59.9% 44.3% N/A
2021 N/A -22.7% 411.9% N/A
2020 N/A 1.5% 150.8% N/A
2019 N/A 5.5% 55.3% N/A

NAV & Total Return History


SKGIX - Holdings

Concentration Analysis

SKGIX Category Low Category High SKGIX % Rank
Net Assets 28.2 M 207 K 34.3 B 92.87%
Number of Holdings 96 7 1180 48.87%
Net Assets in Top 10 5.02 M 57.4 K 2.83 B 95.83%
Weighting of Top 10 17.83% 7.1% 100.1% 79.27%

Top 10 Holdings

  1. Northern Inst Fds TREAS PRT PRMR 2.49%
  2. Super Micro Computer Inc. COM USD0.001 1.98%
  3. Shockwave Medical Inc. COM USD0.001 1.92%
  4. Procept Biorobotics Corp. COM 1.89%
  5. Qualys Inc COM USD0.001 1.68%
  6. Landstar System Inc. COM USD0.01 1.61%
  7. Amphastar Pharmaceuticals Inc COM USD0.0001 1.58%
  8. Procore Technologies Inc COM 1.58%
  9. National Storage Affiliates Trust USD0.01(BEN OF INT) 1.56%
  10. Simpson Manufacturing Co Inc. COM USD0.01 1.54%

Asset Allocation

Weighting Return Low Return High SKGIX % Rank
Stocks
97.60% 77.88% 108.99% 56.70%
Cash
2.49% 0.00% 26.25% 41.57%
Preferred Stocks
0.00% 0.00% 3.53% 15.13%
Other
0.00% -0.22% 5.89% 34.61%
Convertible Bonds
0.00% 0.00% 1.57% 4.52%
Bonds
0.00% 0.00% 3.22% 4.52%

Stock Sector Breakdown

Weighting Return Low Return High SKGIX % Rank
Technology
25.56% 2.91% 75.51% 46.78%
Healthcare
25.37% 0.00% 47.90% 29.22%
Industrials
11.00% 0.00% 36.64% 89.04%
Consumer Cyclical
9.76% 0.00% 24.04% 76.87%
Consumer Defense
7.19% 0.00% 13.56% 9.91%
Communication Services
5.96% 0.00% 15.31% 3.48%
Real Estate
5.21% 0.00% 15.31% 19.48%
Financial Services
4.47% 0.00% 42.95% 75.48%
Utilities
2.99% 0.00% 5.57% 4.17%
Basic Materials
2.50% 0.00% 9.24% 47.30%
Energy
0.00% 0.00% 55.49% 74.26%

Stock Geographic Breakdown

Weighting Return Low Return High SKGIX % Rank
US
97.60% 30.27% 102.09% 47.83%
Non US
0.00% 0.00% 61.74% 28.35%

SKGIX - Expenses

Operational Fees

SKGIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Expense Ratio 1.58% 0.05% 23.20% 24.56%
Management Fee 0.75% 0.05% 1.62% 32.75%
12b-1 Fee N/A 0.00% 1.00% N/A
Administrative Fee N/A 0.01% 0.40% N/A

Sales Fees

SKGIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Front Load N/A 3.50% 5.75% N/A
Deferred Load N/A 1.00% 5.00% N/A

Trading Fees

SKGIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Max Redemption Fee N/A 1.00% 2.00% N/A

Related Fees

Turnover provides investors a proxy for the trading fees incurred by mutual fund managers who frequently adjust position allocations. Higher turnover means higher trading fees.

SKGIX Fees (% of AUM) Category Return Low Category Return High Rank in Category (%)
Turnover N/A 3.00% 439.00% N/A

SKGIX - Distributions

Dividend Yield Analysis

SKGIX Category Low Category High SKGIX % Rank
Dividend Yield 0.00% 0.00% 7.14% 19.83%

Dividend Distribution Analysis

SKGIX Category Low Category High Category Mod
Dividend Distribution Frequency Annual Annually Annual Annual

Net Income Ratio Analysis

SKGIX Category Low Category High SKGIX % Rank
Net Income Ratio N/A -2.47% 1.10% N/A

Capital Gain Distribution Analysis

SKGIX Category Low Category High Capital Mode
Capital Gain Distribution Frequency Annually Annually Semi-Annually Annually

Distributions History

View More +

SKGIX - Fund Manager Analysis

Managers

Brent Lium


Start Date

Tenure

Tenure Rank

Nov 15, 2021

0.54

0.5%

Brent Lium joined Crossmark in November of 2019 as Managing Director with over 24 years of industry experience. His primary role is co-managing the Steward Enhanced Index Funds and the Large Cap Core Growth product. Brent started his investment career in 1995 with Dean Witter in Dallas. Following business school in 2001, he joined Invesco Ltd as an equity analyst on a growth mutual fund team. There he developed his extensive bottoms-up fundamental equity research abilities. He rounded out his top down strategy skills after being promoted to portfolio manager a few years later. Brent earned a BBA in Accounting from Texas A&M University and an MBA in Finance from the University of Texas - Austin. He is also a CFA Charterholder. He lives in West University Place, TX with his wife Carrie and three children. When he is not at one of his kid’s sporting events or activities, he loves to travel and do any outdoor activity.

Tenure Analysis

Category Low Category High Category Average Category Mode
0.08 30.44 9.01 5.25